| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5LO1ZK1LCW |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C26H23Cl2NO6 |
| Molecular Weight | 516.38 |
| AlogP | 5.72 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 94.09 |
| Molecular species | None |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 35.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | G protein-coupled receptor 44 antagonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Asthma | 2 | D001249 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545109 |
| FDA SRS | 5LO1ZK1LCW |
| Guide to Pharmacology | 10179 |
| PubChem | 131633366 |
CONTENTS